Vivotif-b
Product Images NDC 21695-526

1 FDA label image from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Vivotif-b (NDC 21695-526). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vivotif-b (31fe1e75 Da67 4e6d A529 8b82905dad45 01)

Vivotif-b (31fe1e75 Da67 4e6d A529 8b82905dad45 01)
Vivotif-B Capsules label showing the product name and dosage form. It states each dose contains 2-6.8x10 CFU of live attenuated salmonella typhi strain Ty21a, intended as a live oral vaccine for typhoid fever. The label includes lot number #04 and an expiration date placeholder. Distributed by Physician Partner and manufactured by Berna Biotech Ltd, Switzerland, with storage instructions between 2°C and 8°C and caution to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.